Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Validation Studies in Japan
Total 1 results
Nobelpharma
Completed
Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)
Qt Interval, Variation in
Japan
Sponsors and Collaborators
Stanford's Innovative Medicines Accelerator
Robert Pendleton
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Rotem Petranker
National Institute of Diabetes and Endocrinology, Egypt
Daqiao Community Health Service Center of Yangpu District
Michael Scharl
Ancon Technologies Ltd
National Institute of Drug Abuse
Prostate Cure Foundation
Montera Health Texas LLC
Julie Lefevere
Ondine Biomedical Inc.
Azumio Inc.
Genesis Foundation
Spokane Regional Health District
University Mental Health Research Institute, Athens, Greece
AVAX Technologies
Health Factors Inc
Manresana de Micobacteriologia, SL
View Full List
Medical Conditions
Ischemic Stroke, Cryptogenic
Unwanted Abdomen Fat
Isolation of Enterococci From Samples
Convalescent Plasma for COVID 19
Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
Pain Due to Childhood Vaccination
Universal Adhesive
Immunochromatographic
Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
Skin Burn Multiple
Simulation Training, Laparoscopy
Acute Myocardial Infarction With ST Segment Elevation
Peripheral Artery Calcification
Vital Signs
Age of Probands 18 - 55 Years
Thymoglobulin Dose
Desmoid
Connective Active Program
Glanzmann's Thrombasthenia
Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
View Full List
Drug Interventions
Oxaliplatin
Genicular nerve block with lidocaine
Pemetrexed
0.9% sodium chloride
Avatrombopag (higher baseline platelet count)
GSK3145095
Cilengitide
HH-003 and NrtIs
Acitretin
Clonidine 1 mcg/Kg
Pembrolizumab, pemetrexed, platinum
Lotrel® Capsules 10 mg/20 mg
Tremelimumab
Azithromycin 1 gram IV
Vatiquinone
Oxaliplatin and 5-fluorouracil
Human chorionic gonadotropin (hCG), then epoetin alfa (EPO)
Buprenorphine transdermal patch
CDA Inhibitor E7727/Decitabine Combination Agent ASTX727
Morphine ,ketorolac
View Full List
CROs by country
Contract Research Organizations in Finland
Contract Research Organizations in Gambia
Contract Research Organizations in Guinea
Contract Research Organizations in Kosovo
Contract Research Organizations in Macedonia
Contract Research Organizations in Malta
Contract Research Organizations in Mauritania
Contract Research Organizations in Norway
Contract Research Organizations in Oman
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in South Korea
Contract Research Organizations in Trinidad & Tobago
CRO list by country
CROs in Burundi
SGS
All CROs in Burundi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe